Presentation previews · Artwork labels are not verified filling specifications. Purchasing is not available.

AEVIA MED / VIALS
CJC-1295 (No DAC) + Ipamorelin Blend
Endocrine-research blend designation requiring exact constituent verification.
FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR ANIMAL USE.
Do not inject, ingest or otherwise administer to humans or animals.
Research-use policy →Price
Price to confirm
Presentation status
Supplied visual concept. The printed amount is an artwork reference, not confirmation of AEVIA filling, formulation, physical state or use. It is not an application dose.
Research-only intended use
This product is intended solely for laboratory research conducted by appropriately trained personnel in suitable laboratory facilities. It must not be used in or on humans or animals, including by injection, ingestion or topical application.
It is not supplied for clinical, diagnostic, therapeutic, veterinary, cosmetic, food or supplement use. References to published studies describe research context only; they are not instructions or recommendations to use this product in people or animals.
The quantity stated on the container is the total supplied content, not an administration dose. Consult the applicable product documentation and safety data before laboratory handling. A product or batch record match does not establish suitability for human or animal use.
Research-use policy →Compound identity and research context · Separate from the exact product specification
What it is
The label combines a No-DAC CJC designation with ipamorelin.
Biological target / research area
No combined mechanism or amplified hormone effect is established for this product.
What the research examined
Evidence context: constituents and comparator only
The cited records cover a different long-acting CJC analogue and separate ipamorelin experiments.
Evidence limitations
No-DAC identity, blend formulation and interaction evidence are missing. Do not claim synergy or apply single-ingredient trial results to this mixture.
CJC-1295 (No DAC) + Ipamorelin Blend · 10 mg: this printed quantity identifies the artwork presentation. It is not a verified filling specification or an application dose.
Selected references
- Prolonged stimulation of GH and IGF-I by long-acting CJC-1295 (2006) ↗ · Reviewed 14/10/2026
- Ipamorelin, the first selective growth hormone secretagogue (1998) ↗ · Reviewed 14/10/2026
Composition & specification
Verified product specifications and release documentation are pending. No dosing, preparation or administration instructions are provided.
The identity shown on this artwork is still under review. This presentation is excluded from kit selection.
Storage, safety & batch information
Product-specific storage, expiry and safety documentation must be confirmed for the exact released presentation. Use the exact-presentation batch reference lookup in the product guide. A record match does not authenticate physical contents.